300683 Wuhan Hiteck Biological Pharma
- 24.37
- +0.01+0.04%
Wuhan Hiteck Biological Pharma News
Wuhan Hiteck Biological Pharma: Announcement on pledged repurchase transactions of some shares of the controlling shareholder
Wuhan Hiteck Biological Pharma: Announcement on the cancellation of the actual controller's shares pledge
Wuhan Hiteck Biological Pharma: China Investment Securities Co., Ltd. sponsorship summary report on the company's issuance of shares to specific targets in 2020
Haite Biotech: Announcement on pledged repurchase transactions of some shares of the controlling shareholder
Haite Biotech: Announcement on the cancellation of the actual controller's shares pledge
Haite Biotech: Simplified Equity Change Report
Haite Biotech: Detailed Equity Change Report
Haite Biotech: An indicative announcement on changes in the upper shareholder ownership structure of the controlling shareholder, proposed changes in actual controllers, and disclosure of equity change reports
Haite Biotech: Simplified Equity Change Report (2)
Haite Biotech: Simplified Equity Change Report (1)
Haite Biotech: An indicative announcement on the progress of the continuing division of controlling shareholders and changes in equity
Haite Biotech: Announcement on the pledge of some of the shares of the actual controller
Hyte Biotech: An indicative notice on the use of simplified procedures to issue shares to specific targets to lift restrictions on listing circulation
Haite Biotech: Announcement on the pledge of some of the shares of the actual controller
Hyte Biotech: Prompt Announcement on Issuing Shares to Specific Targets and Relieves Listing Restrictions
Haite Biotech: Anxin Securities Co., Ltd.'s listing sponsorship letter for the company to issue shares to specific targets through simplified procedures
Haite Biotech: Issuance of stock issuance reports to specific targets through simple procedures
Haite Biotech: Beijing Zhonglun Law Firm's Legal Opinion on the Company's Stock Issuance Process to Specific Targets Using Simple Procedures and the Compliance of Subscribers
Haite Biotech: Report by Anxin Securities Co., Ltd. on the issuance process of the company issuing shares to specific targets using simplified procedures and the compliance of subscribers
Haite Biotech: Issuance of new stock change reports and listing announcements to specific targets through simplified procedures
Analysis
Price Target
No Data
No Data